This article provides a comprehensive roadmap for researchers, scientists, and drug development professionals aiming to standardize the quantification of ubiquitination across diverse tissue types.
This article addresses the critical challenge of sample heterogeneity in ubiquitination research, a major obstacle to obtaining reproducible and biologically relevant data.
The precise identification of ubiquitination sites is crucial for understanding cellular regulation, disease mechanisms, and developing targeted therapies.
The ubiquitin-proteasome system (UPS) is a critical regulator of oncogenesis, yet the study of low-abundance ubiquitinated proteins presents significant technical challenges.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing protocols for the enrichment of ubiquitinated proteins from complex tissue samples.
This article provides a comprehensive guide for researchers and drug development professionals seeking to minimize background noise in ubiquitylomics datasets.
This article explores the critical intersection of single-cell analysis and ubiquitination states in dissecting tumor heterogeneity, a central challenge in oncology.
This article provides a comprehensive resource for researchers and drug development professionals on the application of ubiquitination-specific antibodies in cancer immunohistochemistry (IHC).
Deubiquitinating enzymes (DUBs) have emerged as a promising therapeutic target class in oncology, with over 100 proteases regulating key cancer-associated proteins.
This article provides a comprehensive overview of how mass spectrometry-based proteomics is revolutionizing our understanding of protein ubiquitination in cancer.